Overview Financials News + Filings Key Docs Charts Ownership Insiders |
IMPERIAL SUGAR CO /NEW (IPSU)
|
Add to portfolio |
|
|
Price: |
$8.01
| | Metrics |
OS: |
12.2
|
M
| |
-22
|
% ROE
|
Market cap: |
$98.1
|
M
| |
-31
|
% ROIC
|
Net debt:
|
$47.3
|
M
| |
|
|
EV:
|
$145
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($32.5)
|
M
| |
|
|
EBIT
|
($53.0)
|
M
| |
|
|
EPS |
($4.91)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Sep-30-11 | Sep-30-10 | Sep-30-09 | Sep-30-08 | Sep-30-07 | Sep-30-06 | Sep-30-05 | Sep-30-04 |
Revenues | 848.0 | 908.0 | 522.6 | 592.4 | 875.5 | 946.8 | 803.8 | 785.9 |
Revenue growth | -6.6% | 73.8% | -11.8% | -32.3% | -7.5% | 17.8% | 2.3% | -14.6% |
Cost of goods sold | 861.5 | 927.3 | 511.5 | 585.9 | 782.0 | 827.6 | 761.5 | 723.3 |
Gross profit | -13.5 | -19.3 | 11.1 | 6.5 | 93.5 | 119.2 | 42.2 | 62.6 |
Gross margin | -1.6% | -2.1% | 2.1% | 1.1% | 10.7% | 12.6% | 5.3% | 8.0% |
Selling, general and administrative | 38.0 | 41.4 | 45.8 | 45.4 | 52.3 | 47.4 | 43.1 | 39.4 |
EBIT | -50.2 | 209.2 | -25.8 | -66.2 | 53.7 | 71.7 | -10.7 | 11.8 |
EBIT margin | -5.9% | 23.0% | -4.9% | -11.2% | 6.1% | 7.6% | -1.3% | 1.5% |
Pre-tax income | -47.9 | 60.7 | -7.8 | -51.8 | 57.3 | 73.7 | -8.1 | 8.3 |
Income taxes | 5.5 | -76.2 | 16.1 | -30.6 | 13.8 | 25.3 | -2.6 | 0.8 |
Tax rate | | | | 59.1% | 24.0% | 34.3% | 32.5% | 9.2% |
Earnings from continuing ops | -53.4 | 136.9 | -23.8 | -21.2 | 43.6 | 48.4 | -5.4 | 7.5 |
Earnings from discontinued ops | | | | | | | -19.3 | 15.0 |
Net income | -53.4 | 136.9 | -23.2 | -20.9 | 40.2 | 50.1 | -24.8 | 22.5 |
Net margin | -6.3% | 15.1% | -4.4% | -3.5% | 4.6% | 5.3% | -3.1% | 2.9% |
|
Diluted EPS | ($4.49) | $11.33 | ($2.03) | ($1.82) | $3.71 | $4.31 | ($0.52) | $0.69 |
Shares outstanding (diluted) | 11.9 | 12.1 | 11.7 | 11.7 | 11.7 | 11.2 | 10.5 | 10.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|